Amblyopia Market Research Report- Global Forecast Till 2027

Amblyopia Market Information: By Type (Strabismus Amblyopia, Refractive Amblyopia), Diagnosis (Visual Acuity Tests, Photo Screening), Treatment (Eye Patches, Atropine Drops, Glasses, Video Game), End-User (Ophthalmic Clinics) – Global Forecast Till 2027

ID: MRFR/MED/2967-HCR | February 2021 | Region: Global | 108 pages

Please note that the assessment period of report has been updated from 2018-2025 to 2020-2027. Cordially fill the sample form for updated data

Market Scenario


Amblyopia is an eye disorder which leads to decreased vision in one or both the eyes due to suppressed input from the brain. The most common cause of amblyopia is a refractive error in one or both eyes, or it might even occur due to muscle imbalance. The other cause of amblyopia is if the infant is born with a cataract, which causes cloudy images. There are four types of amblyopia, namely, Strabismus Amblyopia, Refractive Amblyopia, Deprivation Amblyopia, and Reverse Amblyopia. The global prevalence rate of Amblyopia is 2 to 3% of the infant population. Amblyopia market is driven by growing incidence of ophthalmological disorders such as cataracts, macular degeneration, glaucoma, and refractive errors. According to reports published by the United Kingdom Statistics Authority, in 2015, around 15,900 people were registered as visually impaired. Moreover, according to the Journal of Ophthalmology, as of 2014 there were around 28 million visually impaired people in the European region. With the increasing prevalence, there is increasing in the advancement of treatment and hence influencing the growth of the market. 


Global Amblyopia Market is expected to grow at a CAGR of 3.80% during the forecast period 2017-2023.


 Intended Audience



  • Medical Device Manufacturers

  • Pharmaceutical Manufacturers

  • Research and Development (R&D) Companies

  • Market Research and Consulting Service Providers

  • Potential Investors


Research Methodology


 Amblyopia Methodology


Source: World Health Organization, Centers for Disease Control and Prevention, expert interview market research future analysis, annual report, white paper, company presentation


Segmentation


The global amblyopia market is segmented on the basis of type, diagnosis, treatment, and end-user.


On the basis the type, it is segmented into strabismus amblyopia, refractive amblyopia, deprivation amblyopia, reverse amblyopia, and other.


On the basis of the diagnosis, it is segmented into visual acuity tests, photo screening, Bruckner test and others.


On the basis of the treatment, it is segmented into eye patches, atropine drops, glasses, video game and others.


On the basis of the end-user, it is segmented into hospitals & pharmacies, ophthalmic clinics, and others.


Figure: Global Amblyopia in the Age of Personalized Nutrition Market, by type, 2016 (%)


 Amblyopia Market


Source: National Health Service, Centers for Disease Control and Prevention, World Health Organization, Food and Drug Administration, National Eye Institute, Pediatric Eye Disease Investigator Group (PEDIG), American Academy of Ophthalmology, World Bank, Expert Interview Market Research Future Analysis, Annual report, White paper, Company Presentation


Key Findings



  • The global amblyopia market was USD 4327.0 million in 2016

  • Strabismus amblyopia is the largest segment, by type which is projected to grow at a CAGR of 3.47% during the forecast period from 2017-2023

  • Eye patches is the largest segment, by treatment for the global amblyopia and expected to grow at a rate of CAGR 3.93% during the forecast period

  • Currently, the Americas accounted for the largest market share in the global scenario, whereas Asia Pacific is expected to be the fastest growing segment.


Key Players


Some of the key players in this market are Amblyoptica (Holding) Pty Ltd, Amblyotech, Inc, Good-Lite Co, Vivid Vision, Inc., Cooper Vision, Johnson & Johnson, Novartis AG., Carl Zeiss AG, HOYA Corporation, Krafty Eye Patches¸ Fresnel Prism and Lens Co., Hilco Vision, McKesson Corporation, and others.


Regional Analysis


The global amblyopia market, on the basis of region, is divided into the Americas, Europe, Asia Pacific and the Middle East & Africa. The Americas accounted for the largest market share of 37.9% in 2016 for global amblyopia market. This large share is majorly attributed due to the increasing prevalence of ophthalmological disorders, the presence of major manufacturers, increasing technological advancement and high healthcare expenditure. Europe accounts for the second largest market share, whereas Asia Pacific is expected to grow at the fastest rate with 4.35% CAGR for the forecast period. With lots of opportunity and continuously growing economies, the presence of huge patient population, rapid development in technology and presence of a huge opportunity for the development the region is expected to be the fastest growing region. The Middle East & Africa is growing at a slow pace, and the low income accounted for the least market share in 2016 but is expected to grow in the coming future.



Frequently Asked Questions (FAQ) :


Amblyopia Market is projected to grow at a 3.80% CAGR between 2017-2023.

Different end users of Amblyopia Market include ophthalmic clinics, hospitals and pharmacies, and others.

The Americas is expected to lead the Amblyopia Market.

Eye patches segment will lead the Amblyopia Market.

Rising incidence of various ophthalmological disorders is adding market growth.

[{"chapter_no"=>"1", "title"=>" Report Prologue", "enterprise_usd"=>1350, "description"=>nil}, {"chapter_no"=>"2", "title"=>"Introduction", "enterprise_usd"=>0, "description"=>"2.1 Market Definition 16\n2.2 Scope of Study 16\n2.3 Research Objective 16\n2.4 Assumptions & Limitations 16\n2.4.1 Assumptions 16\n2.4.2 Limitations 16\n"}, {"chapter_no"=>"3", "title"=>" Research Methodology ", "enterprise_usd"=>0, "description"=>"3.1.1 Primary Research Methodology 19\n3.1.2 Secondary Research Methodology 20\n3.1.3 Market Share Analysis 20\n3.1.4 Market Pricing Approach 20\n"}, {"chapter_no"=>"4", "title"=>"Market Dynamics ", "enterprise_usd"=>950, "description"=>"4.1 Introduction 23\n4.2 Drivers 24\n4.2.1 Increasing Prevalence of Ophthalmological Disorders 24\n4.2.2 Favorable Government Funding 25\n4.2.3 Product Advancements 26\n4.3 Restraints 27\n4.3.1 Lack of Awareness 27\n4.3.2 Longer Duration of Treatment 28\n4.4 Opportunity 29\n4.4.1 Entering untapped markets 29\n4.5 Mega Trend 30\n4.5.1 Technological Trends 30\n4.6 Macroeconomics 30\n"}, {"chapter_no"=>"5", "title"=>"Market Factor Analysis ", "enterprise_usd"=>950, "description"=>"5.1 Value Chain Analysis 32\n5.1.1 R&D 32\n5.1.2 Manufacturing 32\n5.1.3 Distribution & Sales 32\n5.1.4 Post-sales Monitoring 33\n5.2 Porter’s Five Forces Model 33\n5.2.1 Bargaining Power of Suppliers 33\n5.2.2 Bargaining Power of Buyers 34\n5.2.3 Threat of New Entrants 34\n5.2.4 Threat of Substitutes 34\n5.2.5 Intensity of Rivalry 34\n5.3 Investment Opportunities 34\n5.4 Pricing Analysis 34\n5.5 Demand & Supply: Gap Analysis 35\n"}, {"chapter_no"=>"6", "title"=>"Global Amblyopia Market By Type ", "enterprise_usd"=>1650, "description"=>"6.1 Introduction 37\n6.1.1 Strabismus Amblyopia 38\n6.1.2 Refractive Amblyopia 38\n6.1.3 Deprivation Amblyopia 38\n6.1.4 Reverse Amblyopia 39\n"}, {"chapter_no"=>"7", "title"=>"Global Amblyopia Market By Diagnosis ", "enterprise_usd"=>1650, "description"=>"7.1 Introduction 41\n7.1.1 Visual acuity tests 41\n7.1.2 Photo screening 41\n7.1.3 Bruckner test 41\n"}, {"chapter_no"=>"8", "title"=>"Global Amblyopia Market By Treatment ", "enterprise_usd"=>1650, "description"=>"8.1 Introduction 43\n8.1.1 Eye Patches 44\n8.1.2 Atropine Drops 44\n8.1.3 Glasses 45\n8.1.4 Video game 45\n"}, {"chapter_no"=>"9", "title"=>"Global Amblyopia Market By End User ", "enterprise_usd"=>1650, "description"=>"9.1 Introduction 47\n9.1.1 Hospitals & Pharmacies 48\n9.1.2 Ophthalmic Clinics 48\n"}, {"chapter_no"=>"10", "title"=>"Global Amblyopia Market By Region ", "enterprise_usd"=>1650, "description"=>"10.1 Americas 51\n10.1.1 North America 53\n10.1.1.1 U.S. 55\n10.1.1.2 Canada 56\n10.1.2 South America 57\n10.2 Europe 59\n10.2.1 Western Europe 61\n10.2.1.1 Germany 63\n10.2.1.2 France 64\n10.2.1.3 U.K. 65\n10.2.1.4 Italy 66\n10.2.1.5 Spain 67\n10.2.1.6 Rest of Western Europe 68\n10.2.2 Eastern Europe 69\n10.3 Asia Pacific 71\n10.3.1 Japan 73\n10.3.2 China 74\n10.3.3 India 75\n10.3.4 Australia 76\n10.3.5 Republic of Korea 77\n10.3.6 Rest of Asia Pacific 78\n10.4 Middle East & Africa 80\n10.4.1 Middle East 82\n10.4.2 Africa 84\n"}, {"chapter_no"=>"11", "title"=>"Company Landscape ", "enterprise_usd"=>1050, "description"=>"11.1 Key Player Analysis, by Product 87\n11.1.1 Patches 87\n11.1.2 Video Games 87\n11.1.3 Glasses 87\n11.2 Key Growth Strategy Analysis 87\n11.3 Recent key developments 87\n"}, {"chapter_no"=>"12", "title"=>"Company Profile ", "enterprise_usd"=>900, "description"=>"12.1 Amblyoptica (Holding) Pty Ltd 90\n12.1.1 Company Overview 90\n12.1.2 Financials 90\n12.1.3 Products 90\n12.1.4 Strategy 90\n12.1.5 Key Developments 90\n12.2 Amblyotech, Inc. 91\n12.2.1 Company Overview 91\n12.2.2 Financials 91\n12.2.3 Products 91\n12.2.4 Strategy 91\n12.2.5 Key Developments 91\n12.3 Good-Lite Co 92\n12.3.1 Company Overview 92\n12.3.2 Financials 92\n12.3.3 Products 92\n12.3.4 Strategy 92\n12.3.5 Key Developments 92\n12.4 Vivid Vision, Inc. 93\n12.4.1 Company Overview 93\n12.4.2 Financials 93\n12.4.3 Products 93\n12.4.4 Strategy 93\n12.4.5 Key Developments 93\n12.5 CooperVision 94\n12.5.1 Company Overview 94\n12.5.2 Financials 94\n12.5.3 Products 94\n12.5.4 Strategy 94\n12.5.5 Key Developments 94\n12.6 Johnson & Johnson 95\n12.6.1 Company Overview 95\n12.6.2 Financials 95\n12.6.3 Products 95\n12.6.4 Strategy 95\n12.6.5 Key Developments 95\n12.7 Novartis AG. 96\n12.7.1 Company Overview 96\n12.7.2 Financials 96\n12.7.3 Products 96\n12.7.4 Strategy 96\n12.7.5 Key Developments 96\n12.8 Carl Zeiss AG 97\n12.8.1 Company Overview 97\n12.8.2 Financials 97\n12.8.3 Products 97\n12.8.4 Strategy 97\n12.8.5 Key Developments 97\n12.9 HOYA Corporation 98\n12.9.1 Company Overview 98\n12.9.2 Financials 98\n12.9.3 Products 98\n12.9.4 Strategy 98\n12.9.5 Key Developments 98\n12.10 Krafty Eye Patches. 99\n12.10.1 Company Overview 99\n12.10.2 Financials 99\n12.10.3 Products 99\n12.10.4 Strategy 99\n12.10.5 Key Developments 99\n12.11 Fresnel Prism and Lens Co. 100\n12.11.1 Company Overview 100\n12.11.2 Financials 100\n12.11.3 Products 100\n12.11.4 Strategy 100\n12.11.5 Key Developments 100\n12.12 Hilco Vision 101\n12.12.1 Company Overview 101\n12.12.2 Financials 101\n12.12.3 Products 101\n12.12.4 Strategy 101\n12.12.5 Key Developments 101\n12.13 McKesson Corporation 102\n12.13.1 Company Overview 102\n12.13.2 Financials 102\n12.13.3 Products 102\n12.13.4 Strategy 102\n12.13.5 Key Developments 102\n"}, {"chapter_no"=>"13", "title"=>"Conclusion ", "enterprise_usd"=>750, "description"=>"13.1 Key Findings 104\n13.1.1 The CEO’s Viewpoint 104\n13.1.2 Unmet Needs 104\n13.1.3 Key Companies to Watch 104\n13.1.4 Prediction of Amblyopia Industry 104\n"}, {"chapter_no"=>"14", "title"=>"Appendix ", "enterprise_usd"=>0, "description"=>"14.1 Discussion Blue Print 106\n14.2 References 107\n"}, {"chapter_no"=>"15", "title"=>"List of Tables", "enterprise_usd"=>nil, "description"=>"TABLE 1 PRIMARY INTERVIEWS 20\nTABLE 2 GLOBAL AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION) 37\nTABLE 3 GLOBAL AMBLYOPIA MARKET, BY STRABISMUS AMBLYOPIA 2014-2023 (USD MILLION) 38\nTABLE 4 GLOBAL AMBLYOPIA MARKET, BY REFRACTIVE AMBLYOPIA 2014-2023 (USD MILLION) 38\nTABLE 5 GLOBAL AMBLYOPIA MARKET, BY DEPRIVATION AMBLYOPIA 2014-2023 (USD MILLION) 38\nTABLE 6 GLOBAL AMBLYOPIA MARKET, BY REVERSE AMBLYOPIA 2014-2023 (USD MILLION) 39\nTABLE 7 GLOBAL AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION) 44\nTABLE 8 GLOBAL AMBLYOPIA MARKET, EYE PATCHES 2014-2023 (USD MILLION) 44\nTABLE 9 GLOBAL AMBLYOPIA MARKET, ATROPINE DROPS 2014-2023 (USD MILLION) 44\nTABLE 10 GLOBAL AMBLYOPIA MARKET, GLASSES 2014-2023 (USD MILLION) 45\nTABLE 11 GLOBAL AMBLYOPIA MARKET, VIDEO GAME 2014-2023 (USD MILLION) 45\nTABLE 12 GLOBAL AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION) 47\nTABLE 13 GLOBAL AMBLYOPIA MARKET, HOSPITALS & PHARMACIES 2014-2023 (USD MILLION) 48\nTABLE 14 GLOBAL AMBLYOPIA MARKET, OPHTHALMIC CLINICS 2014-2023 (USD MILLION) 48\nTABLE 15 GLOBAL AMBLYOPIA MARKET, BY REGION 2014-2023 (USD MILLION) 50\nTABLE 16 AMERICAS AMBLYOPIA MARKET, BY REGION 2014-2023 (USD MILLION) 52\nTABLE 17 AMERICAS AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION) 52\nTABLE 18 AMERICAS AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION) 53\nTABLE 19 AMERICAS AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION) 53\nTABLE 20 NORTH AMERICA AMBLYOPIA MARKET, BY COUNTRY 2014-2023 (USD MILLION) 54\nTABLE 21 NORTH AMERICA AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION) 54\nTABLE 22 NORTH AMERICA AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION) 54\nTABLE 23 NORTH AMERICA AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION) 55\nTABLE 24 U.S. AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION) 55\nTABLE 25 U.S. AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION) 55\nTABLE 26 U.S. AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION) 56\nTABLE 27 CANADA AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION) 56\nTABLE 28 CANADA AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION) 56\nTABLE 29 CANADA AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION) 57\nTABLE 30 SOUTH AMERICA AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION) 57\nTABLE 31 SOUTH AMERICA AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION) 57\nTABLE 32 SOUTH AMERICA AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION) 58\nTABLE 33 EUROPE AMBLYOPIA MARKET, BY REGION 2014-2023 (USD MILLION) 60\nTABLE 34 EUROPE AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION) 60\nTABLE 35 EUROPE AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION) 61\nTABLE 36 EUROPE AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION) 61\nTABLE 37 WESTERN EUROPE AMBLYOPIA MARKET, BY COUNTRY 2014-2023 (USD MILLION) 62\nTABLE 38 WESTERN EUROPE AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION) 62\nTABLE 39 WESTERN EUROPE AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION) 62\nTABLE 40 WESTERN EUROPE AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION) 63\nTABLE 41 GERMANY AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION) 63\nTABLE 42 GERMANY AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION) 63\nTABLE 43 GERMANY AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION) 64\nTABLE 44 FRANCE AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION) 64\nTABLE 45 FRANCE AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION) 64\nTABLE 46 FRANCE AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION) 65\nTABLE 47 U.K. AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION) 65\nTABLE 48 U.K. AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION) 65\nTABLE 49 U.K. AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION) 66\nTABLE 50 ITALY AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION) 66\nTABLE 51 ITALY AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION) 66\nTABLE 52 ITALY AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION) 67\nTABLE 53 SPAIN AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION) 67\nTABLE 54 SPAIN AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION) 67\nTABLE 55 SPAIN AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION) 68\nTABLE 56 REST OF WESTERN EUROPE AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION) 68\nTABLE 57 REST OF WESTERN EUROPE AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION) 68\nTABLE 58 REST OF WESTERN EUROPE AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION) 69\nTABLE 59 EASTERN EUROPE AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION) 69\nTABLE 60 EASTERN EUROPE AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION) 69\nTABLE 61 EASTERN EUROPE AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION) 70\nTABLE 62 ASIA PACIFIC AMBLYOPIA MARKET, BY COUNTRY 2014-2023 (USD MILLION) 72\nTABLE 63 ASIA PACIFIC AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION) 72\nTABLE 64 ASIA PACIFIC AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION) 73\nTABLE 65 ASIA PACIFIC AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION) 73\nTABLE 66 JAPAN AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION) 73\nTABLE 67 JAPAN AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION) 74\nTABLE 68 JAPAN AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION) 74\nTABLE 69 CHINA AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION) 74\nTABLE 70 CHINA AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION) 75\nTABLE 71 CHINA AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION) 75\nTABLE 72 INDIA AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION) 75\nTABLE 73 INDIA AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION) 76\nTABLE 74 INDIA AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION) 76\nTABLE 75 AUSTRALIA AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION) 76\nTABLE 76 AUSTRALIA AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION) 77\nTABLE 77 AUSTRALIA AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION) 77\nTABLE 78 REPUBLIC OF KOREA AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION) 77\nTABLE 79 REPUBLIC OF KOREA AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION) 78\nTABLE 80 REPUBLIC OF KOREA AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION) 78\nTABLE 81 REST OF ASIA PACIFIC AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION) 78\nTABLE 82 REST OF ASIA PACIFIC AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION) 79\nTABLE 83 REST OF ASIA PACIFIC AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION) 79\nTABLE 84 MIDDLE EAST & AFRICA AMBLYOPIA MARKET, BY REGION 2014-2023 (USD MILLION) 81\nTABLE 85 MIDDLE EAST & AFRICA AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION) 81\nTABLE 86 MIDDLE EAST & AFRICA AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION) 82\nTABLE 87 MIDDLE EAST & AFRICA AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION) 82\nTABLE 88 MIDDLE EAST AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION) 82\nTABLE 89 MIDDLE EAST AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION) 82\nTABLE 90 MIDDLE EAST AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION) 84\nTABLE 91 AFRICA AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION) 84\nTABLE 92 AFRICA AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION) 84\nTABLE 93 AFRICA AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION) 85\n\n \n"}, {"chapter_no"=>"16", "title"=>"List of Figures", "enterprise_usd"=>nil, "description"=>"FIGURE 1 GLOBAL AMBLYOPIA MARKET 17\nFIGURE 2 RESEARCH METHODOLOGY 19\nFIGURE 3 GLOBAL AMBLYOPIA MARKET: FORECAST MODEL 21\nFIGURE 4 VALUE CHAIN - GLOBAL AMBLYOPIA MARKET 32\nFIGURE 5 PORTERS FIVE FORCES MODEL-GLOBAL AMBLYOPIA MARKET 33\nFIGURE 6 GLOBAL AMBLYOPIA MARKET, BY TYPE 2017 & 2023 (USD MILLION) 37\nFIGURE 7 GLOBAL AMBLYOPIA MARKET, BY TREATMENT 2017 & 2023 (USD MILLION) 43\nFIGURE 8 GLOBAL AMBLYOPIA MARKET, BY END USER 2017 & 2023 (USD MILLION) 47\nFIGURE 9 GLOBAL AMBLYOPIA MARKET, BY REGION 2017 & 2023 (USD MILLION) 50\nFIGURE 10 AMERICAS AMBLYOPIA MARKET, BY REGION 2017 & 2023 (USD MILLION) 52\nFIGURE 11 NORTH AMERICA AMBLYOPIA MARKET, BY COUNTRY 2017 & 2023 (USD MILLION) 53\nFIGURE 12 EUROPE AMBLYOPIA MARKET, BY REGION 2017 & 2023 (USD MILLION) 60\nFIGURE 13 WESTERN EUROPE AMBLYOPIA MARKET, BY COUNTRY 2017 & 2023 (USD MILLION) 61\nFIGURE 14 ASIA PACIFIC AMBLYOPIA MARKET, BY COUNTRY 2017 & 2023 (USD MILLION) 72\nFIGURE 15 MIDDLE EAST & AFRICA AMBLYOPIA MARKET, BY REGION 2014-2023 (USD MILLION) 81\n\n \n"}]